These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3879880)

  • 1. [Mycoplasma infection as a possible cause of hybridoma instability].
    Volgareva GM; Neustroeva VV; Sviridov VV
    Mol Gen Mikrobiol Virusol; 1985 Jan; (1):34-8. PubMed ID: 3879880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
    Hamano T; Leiserson WM; Asofsky R
    J Immunol; 1983 Jul; 131(1):98-102. PubMed ID: 6408183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Karyologic research on murine B-cell hybridomas].
    Volgareva GM
    Tsitologiia; 1985 Dec; 27(12):1394-403. PubMed ID: 4089964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphocytochemical and electron microscopic research on murine hybridoma cells producing and not producing monoclonal antibodies].
    Sidorenko SP; Gluzman DF; Vetrova EP; Iurchenko OV; Berdova AG
    Tsitologiia; 1988 Jan; 30(1):39-43. PubMed ID: 3358281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High efficiency creation of human monoclonal antibody-producing hybridomas.
    Dessain SK; Adekar SP; Stevens JB; Carpenter KA; Skorski ML; Barnoski BL; Goldsby RA; Weinberg RA
    J Immunol Methods; 2004 Aug; 291(1-2):109-22. PubMed ID: 15345310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An IL 2-secreting T cell hybridoma that responds to a self class I histocompatibility antigen in the H-2D region.
    Endres RO; Marrack P; Kappler JW
    J Immunol; 1983 Oct; 131(4):1656-62. PubMed ID: 6604749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Karyotype analysis of hybridomas producing monoclonal antibodies against different antigens.
    Kontsek P; Novák M; Kontseková E
    Folia Biol (Praha); 1988; 34(2):99-104. PubMed ID: 3396730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies to rat renal antigens.
    Shimizu F; Orikasa M; Sato K; Oite T
    Immunology; 1984 Jun; 52(2):319-23. PubMed ID: 6376337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybridoma process: ultrastructural cytology of different stages.
    Feliu E; Rozman C; Berga L; Vilella R; Vives J; Ferrán MJ; Climent C; Vives Corrons JL
    J Submicrosc Cytol; 1987 Jan; 19(1):35-42. PubMed ID: 3560292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse.
    Kametani Y; Shiina M; Katano I; Ito R; Ando K; Toyama K; Tsukamoto H; Matsumura T; Saito Y; Ishikawa D; Taki T; Ito M; Imai K; Tokuda Y; Kato S; Tamaoki N; Habu S
    Exp Hematol; 2006 Sep; 34(9):1240-8. PubMed ID: 16939817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
    White J; Haskins KM; Marrack P; Kappler J
    J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hapten-specific B cell repertoire probed by hybridoma technology: selection and characterization of representative clonotypes from the antibody-forming cell pool.
    Bloor AG; Jou Y; Hoeplinger C; Gartner JE; Mayers GL; Bankert RB
    J Immunol; 1982 Mar; 128(3):1443-9. PubMed ID: 6173438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serum independent medium effective in all aspects of hybridoma technology and immunological applications.
    Baker P; Knoblock K; Noll L; Wyatt D; Lydersen B
    Dev Biol Stand; 1985; 60():63-72. PubMed ID: 3876250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lymphocyte markers defined by antibodies derived from somatic cell hybrids. I. A hybridoma secreting antibody against a marker specific for human B lymphocytes.
    Brooks DA; Beckman I; Bradley J; McNamara PJ; Thomas ME; Zola H
    Clin Exp Immunol; 1980 Feb; 39(2):477-85. PubMed ID: 6966995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of postfusion cell density on establishment of hybridomas.
    Kontseková E; Novák M; Kontsek P; Borecký L; Lesso J
    Folia Biol (Praha); 1988; 34(1):18-22. PubMed ID: 3391325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional studies on B cell hybridomas with B cell surface antigens. I. Effects of anti-immunoglobulin antibodies on proliferation and differentiation.
    Hamano T; Asofsky R
    J Immunol; 1983 May; 130(5):2027-32. PubMed ID: 6403617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A porcine-murine hybridoma that secretes porcine monoclonal antibody of defined specificity.
    Raybould TJ; Willson PJ; McDougall LJ; Watts TC
    Am J Vet Res; 1985 Aug; 46(8):1768-9. PubMed ID: 3898933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of persistent reovirus infection from a B-cell hybridoma.
    Dermody TS; Chappell JD; Hofler JG; Kramp W; Tyler KL
    Virology; 1995 Sep; 212(1):272-6. PubMed ID: 7676645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.